We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Elevated Blood Sugar a Cardiovascular Disease Risk Not Linked to Cholesterol Levels

By LabMedica International staff writers
Posted on 21 Sep 2014
Individuals with prediabetes and diabetes are at high risk for cardiovascular events such as myocardial infarction that can be predicted by elevated levels of troponin T.

The protein troponin T binds to tropomyosin and helps position it on actin, and with the rest of the troponin complex modulates contraction of striated muscle. More...
In patients with stable coronary artery disease, troponin T concentrations have been found to be significantly associated with the incidence of cardiovascular death and heart failure.

In a recent study, investigators at Johns Hopkins University (Baltimore, MD, USA) reported that individuals with pre-diabetes or diabetes who displayed elevated levels of troponin T were approximately six times more likely to experience a cardiovascular incident than were those with normal blood sugar levels.

These findings were obtained by using a highly sensitive troponin T assay to determine levels of the protein in blood samples from more than 9,000 participants in the Atherosclerosis Risk in Communities Study (ARIC) at two time points. At the first measurement those with diabetes were two and a half times more likely to have elevated troponin levels than those without. At follow-up 14 years later, diabetics with elevated troponin were seen to be six times more likely to develop heart failure and four times more likely to have a heart attack.

Due to the link between cardiovascular disease and diabetes, patients with newly diagnosed diabetes are typically prescribed a cholesterol-lowering statin. "However, this study suggests that there may be people with diabetes whose heart risk may have nothing to do with cholesterol," said first author Dr. Elizabeth Selvin, associate professor of epidemiology at Johns Hopkins University. "Statin treatment may not be sufficient to prevent damage to the heart in people with diabetes. Even though there may be no symptoms yet, our research suggests there is microvascular damage being done to the heart which is leading to heart failure and even death. It puts what we know about heart damage in diabetes on its head. It looks like diabetes may be slowly killing heart muscle in ways we had not thought of before."

The study was published in the August 2014 online edition of the journal Circulation.

Related Links:
Johns Hopkins University


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Benchtop Cooler
PCR-Cooler & PCR-Rack
New
Nutating Mixer
Enduro MiniMix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.